E. REFERENCES

American Society of Human Genetics Board of Directors and American College of Medical Genetics Board of Directors (1995) Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 57:1233-1241

Bishop DT (1994) BRCA1, BRCA2, BRCA3 ... a myriad of breast cancer genes. Euro J Cancer 30A:1738-1739

Breast Cancer Information Core Data Base (1996) personal communication.

Breast-ovarian cancer screening (October 1996) Committee opinion no. 176, American College of Obstetrics and Gynecology, Washington, DC

Burke W, Daly M, Garber J, Botkin J, Kahn MJE, Lynch P, Offit K, Petersen G, Thomson E (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Studies Consortium; Ethical, Legal, and Social Implications Branch; National Center for Human Genome Research. JAMA 277:997-1003

Cancer genetics network approved by NCI advisors to start with eight centers (1996) The Cancer Letter 22(46):1-6

Cancer Incidence and Mortality by County (1989-1993). New York State Department of Health, Bureau of Chronic Disease Epidemiology and Surveillance, Cancer Registry (May, 1997). Contact NYS Cancer Registry, NYS Department of Health, Room 536, Corning Tower, Empire State Plaza, Albany, NY 12237-0679. Phone: (518) 474-2255; E-mail: meh04@health.state.ny.us.

Cannon-Albright LA, Skolnick MH (1996) The genetics of familial breast cancer. Sem Oncol 23:1-5

Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC, Collins FS, Weber BL (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genetics 8:387-391

Claus E, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Cancer 73:643-651

Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324

Cohen, CJ and Roheman, J (1995) Endometrial cancer, management of high-risk and recurrence including the tamoxifen controversy. Cancer, 76: 2044

Cotton RGH (1996) Detection of unknown mutations in DNA: a catch-22. Am J Hum Genet 59:289-291

Croyle RT, Smith KR, Botkin JR, Baty B, Nash J (1997) Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol, 16:63-72

Easton DF, Bishop DT, Ford D, Crockford GP, and the Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52: 678-701

Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271

Egan KM, Newcomb PA, Longnecker MP, Trentham-Dietz A, Baron JA, Trichopoulos D, Stampfer MJ, Willett WC (1996) Jewish religion and risk of breast cancer. Lancet 347:1645-1646

FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O’Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. NEJM 334:143-149

Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S (1993) Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 85:1644-1656

Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695

Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457-1462

Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, Antman K, Russo D, Wood ME, Mullineau L, Isaacs C, Peshkin B, Buys S, Venne V, Rowley PT, Loader S, Offit K, Robson M, Hampel H, Brener D, Winer EP, Clark S, Weber B, Strong LC, Thomas A et al (1998) Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk. J Clin Oncol Vol 16(7)2417-25

Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Institute 81:1879-1886

Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BAJ (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genetics 11:428-433

Green MH (1997) Genetics of breast cancer. Mayo Clin Proc 72:54-65

Hacia JG, Brody L, Chee M, Fodor S, Collins FS (1996) BRCA1 mutation detection using high density oligonucleotide arrays. Am J Hum Genet 59:A34

Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684-1689

Harris JR et al (1993) Cancers of the breast. In: Cancer: Principles & Practice of Oncology, 4th Ed., Eds: Divita, Jr., VT et al; Philadelphia PA, pp. 1264-1332.

Hodgson SV and Maher ER (1993) A Practical Guide to Human Cancer Genetics Cambridge Univ Press, Cambridge, England.

Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA (1996) Growth retardation and tumour inhibition by BRCA1. Nature Genet 12: 298-302

Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL: Assessment and counseling for women with a family history of breast cancer (1995) JAMA 273:577-585

Hudson KL, Rothenberg KH, Andrews LB, Kahn MJE, Collins FS (1995) Genetic discrimination and health insurance: an urgent need for reform. Science 270:391-393

Kash KM, Holland JC, Halper MS, Miller DG (1992) Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84:24-30

Kerlikowske K, Grady D, Barclay J, Sickies EA, Eaton A, Ernster V (1993) Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 270:2444-2450

Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823

Kosary CL, Reis LAG, Miller BA, Hankey BF, Harras A, and Edwards BK (eds) (1995) SEER Cancer Statistics Review, 1973-’92: Tables and Graphs, National Cancer Institute. NIH Pub No 96-2789. Bethesda, MD.

Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. NEJM 334:137-142

Lerman C, Daly M, Masny A, Balshem A (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843-850

Lerman C (1994) Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 154:609-616

Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Balshem A (1995) Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 87:286-292

Lerman CL, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H (1996) BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA, 275:1885-1892

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM (1997) Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 89:148

Lopez MJ, Porter KA (1996) The current role of prophylactic mastectomy. Surg Clin N Amer 76:231-242

Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Lui Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71

Narod S, Ford D, Devilee P, Barkardottir RB, Eyfjord J, Lenoir G, Serova O, Easton D, Goldgar D, and the Breast Cancer Linkage Consortium (1995) Genetic heterogeneity of breast-ovarian cancer revisited. Am J Hum Genet 57:957-958

Narod SA, Risch H, Moslehi R, Dorum A, Neuhausen S, Olsson H, Provencher D, Radice P, Evans G, Bishop S, Brunet J-S, and Ponder BAJ for the Hereditary Ovarian Cancer Clinical Study Group (1998) Oral contraceptives and the risk of hereditary ovarian cancer. NEJM 339:424-8

National Advisory Council on Human Genome Research (1994) Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA 271:785

Nayfield SG, Karp JE, Ford LG, Dorr FA, Kramer BS (1991) Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83:1450-1459

NIH Consensus Development Panel on Ovarian Cancer (1995) JAMA 273:491-497

Oddoux C, Struewing JP, Clayton CM, Brody LC, Neuhausen S, Kaback M, Goldgar D, Ostrer H, Offit K (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Am J Hum Genet 59:A34

Offit K, Brown K (1994) Quantitating familial cancer risk: a resource for clinical oncologists. J Clin Oncol 12:1724-1736

Offit K, Gilewski T, McGuire P, Schluger A, Hampel H, Brown K, Swensen J, Neuhausen S, Skolnick M, Norton L, Goldgar D (1996) Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347:1643-1645

Pinn VW, Jackson DM (1996) ORWH update: advisory committee to NIH office passes resolutions. J Women’s Health 5:549-553

Radford DM, Zehnbauer BA (1996) Inherited breast cancer. Surg Clin N Amer 76:205-220

Rao VN, Shao N, Ahmad M, Reddy ES (1996) Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene 12:523-528

Resolution on Prenatal and Childhood Testing for Adult-Onset Disorders (1995) National Society of Genetic Counselors, Perspect Genet Counsel 17:5

Roa BB, Boyd AA, Richards CS (1996) Ashkenazic Jewish population frequencies of common BRCA1 and BRCA2 breast cancer gene mutations. Am J Hum Genet 59:A34

Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, Brody L, Friedman L, Ostermeyer E, Szabo C, King MC, Jhanwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne M, Black D, Boyhd M, Steel M, Ingles S, Haile R, Lindblom A, Olsson H, Borg A, Bishop DT, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick MH, Goldgar DE (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 273:535-541

Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N (1992) Inherited p53 gene mutations in breast cancer. Cancer Res 52:2984-2986

Statement of the American Society of Clinical Oncology (1996) Genetic testing for cancer susceptibility. J Clin Oncol 14: 1730-1736

Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition (1994) Am J Hum Genet 55:i-iv

Stefanek ME (1995) Bilateral prophylactic mastectomy: issues and concerns. J Natl Cancer Inst Monographs 17:37-42

Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, King MC, Egilsson V, Devilee P, McManus R, Daly PA, Smyth E, Ponder BAJ, Peto J, Cannon-Albright L, Easton DF, Goldgar DE (1994) Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nature Genetics 7:103-107

Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995a) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 11:198-200

Struewing JP, Brody LC, Erdos MR, Kase RG, Giambarresi TR, Smith SA, Collins FS, Tucker MA (1995b) Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 57:1-7

Struewing JP, Watson P, Easton DF, Ponder BAJ, Lynch HT, Tucker MA (1995c) Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monographs 17:33-35

Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC and Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. NEJM 336:1401-8.

Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review 1973-1991 (National Cancer Institute) (1994). Available from the Office of Cancer Communications, National Cancer Institute, 31 Center DR MSC 2580, Building 31, Room 10A19, Bethesda, MD 20892-2580, or by calling 1-800-4-CANCER or on the web at http://www.graylab.ac.uk/cancernet/600110.html.

Szabo CI, King MC (1995) Inherited breast and ovarian cancer. Hum Mol Genet 4:1811-1817

Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-20.

Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet 9:444-450

Walker AP (1997) Genetic Counseling. In: DL Rimoin, JL Connor and RE Pyeritz: Emery and Rimoin’s Principles and Practice of Medical Genetics, 3rd Ed., Churchill Livingston, NY.

Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090

Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Manglon J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Nashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Keisell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse CJ, Lynch H, Narod S, Lenoir G, Eglisson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792

Young RC et al (1993) Cancer of the ovary. In: Cancer: Principles & Practice of Oncology, 4th Ed., Eds: Divita, Jr., VT et al; Philadelphia, PA, pp. 1226-1263.